Ranimustine

Ranimustine (INN, marketed under the tradename Cymerin; also known as MCNU) is a nitrosourea alkylating agent approved in Japan for the treatment of chronic myelogenous leukemia and polycythemia vera.

It has never been filed for FDA evaluation in the United States, where it is not marketed.

单词	Ranimustine
释义	Ranimustine 英语百科 Ranimustine Ranimustine (INN, marketed under the tradename Cymerin; also known as MCNU) is a nitrosourea alkylating agent approved in Japan for the treatment of chronic myelogenous leukemia and polycythemia vera. It has never been filed for FDA evaluation in the United States, where it is not marketed.
随便看	the first of the ten Heavenly Stems the first of the twelve Earthly Branches The First One The First Option the first order branching of the main stem the first order moment compensator the first page The First Part the first party the first person the first place the first principle the first priority the first prize the first quarter the first reading the first round thefirsts the firsts the first second reading the first snow the first sound The First Step the first string The first stroke is half the battle.